Mortgages Set for Worst September Performance in Half a Decade
(Bloomberg) -- Mortgage-backed securities are on track for their worst September performance in five years despite massive support from the Federal Reserve.
As of Tuesday's close, the Bloomberg Barclays U.S. MBS index month-to-date excess return versus Treasuries stands at -0.18%. That would be the worst performance for mortgage-backed securities for the month since the -0.20% seen in September 2015 if the level holds through Wednesday. The average monthly excess return during September over the last decade has been 0.09%.
The benchmark is also likely to record its worst performance for the first nine months of a year since 2015 with a loss of -0.56%. Unlike that year -- when the Fed wasn't growing mortgages on its balance sheet -- the current underperformance is taking place despite the central bank adding around $40 billion of MBS each month. This highlights the headwinds facing the sector as elevated supply, fast prepayment speeds and the risk of forbearance have proved a potent mix.
Consensus on the Street is that supply will remain elevated at least through year-end, with Nomura Holdings Inc. increasing its forecast to $430 billion net for 2020, which would be the highest total since 2009. Record low mortgage rates have spurred home purchasing, cash-out refinancings and rapid home price appreciation, all of which can push net supply higher. Last month, for example, saw record agency MBS net supply of $74 billion, according to Bank of America Corp., a total well above the take down of the central bank.
Prepayment speeds have moved sideways of late, though at an elevated pace. Aggregate Fannie Mae 30-year speeds have increased to 32.8 CPR in August from 32.5 in June, a less than 1% rise, but that level is still almost twice the 17.4 CPR seen the previous August. Forecasts see the 10-year Treasury yield little changed by year-end, and combined with a Fed back on the zero-bound this should keep many American homeowners with incentive to refinance.
A conditional prepayment rate (CPR) is a loan prepayment rate equivalent to the proportion of a loan pool's principal that is assumed to be paid off ahead of time in each period.
Forbearance remains a concern for Ginnie Mae mortgage bond investors with 9.2% of the overall universe -- over twice that seen in conventionals -- currently taking advantage of it. With 70% of those forbearance agreements ending during this month and next, buyouts, which act much like prepayments to mortgage investors, could be a near-term problem in the Ginnie space.
As the latest FOMC statement seems to promise to keep rates at zero and quantitative easing at its current pace, support for the mortgage sector is likely to remain in place. Whether that will be enough to overcome the headwinds and produce excess return for the sector as a whole remains to be seen.
Yet, if one is partial to the investing maxim “don't fight the Fed,” it's noteable that the Fannie Mae 30-year 2% and 2.5% coupons, which are the focus of the bank's purchasing, sport positive year-to-date excess returns of 0.66% and 1.48%, respectively.
- Christopher Maloney is a market strategist and former portfolio manager who writes for Bloomberg. The observations he makes are his own and are not intended as investment advice
©2020 Bloomberg L.P.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.